EP2838920
And-BAFF-og-and-IL-17 tvísértækt mótefni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.4.2013EP published:
1.2.2017EP application number:
13726321.6
EP translation filed:
13.2.2017Grant published:
15.3.2017EPO information:
European Patent Register
Max expiry date:
15.4.2033Expiry date:
15.4.2022
Title:
ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES
Timeline
Today
16.4.2013EP application
1.2.2017EP Publication
13.2.2017Translation submitted
15.3.2017Registration published
15.4.2022Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
ALLAN, BarrettAddress:
Indianapolis, Indiana, US
Name:
BENSCHOP, Robert JanAddress:
Indianapolis, Indiana, US
Name:
LU, JirongAddress:
Indianapolis, Indiana, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261636302 PDate:
20.4.2012Country:
US
Number:
201361768747 PDate:
25.2.2013Country:
US
Classification
Categories:
C07K 16/24, C07K 16/28, C07K 16/46
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 2.3.2017
Expires: 15.4.2018
Payer: Árnason Faktor
Number: 6
Paid: 13.3.2018
Expires: 15.4.2019
Payer: Örn Þór, slf.
Number: 7
Paid: 13.3.2019
Expires: 15.4.2020
Payer: Örn Þór, slf.
Number: 8
Paid: 13.3.2020
Expires: 15.4.2021
Payer: Örn Þór slf.
Number: 9
Paid: 23.3.2021
Expires: 15.4.2022
Payer: Patice ehf.